SCP-8056
Necropsar
~
medium confidence
SCP-8056
Expected annual
$1.9M
One-time setup
$2.1M
Annual recurring
$1.8M
Personnel
10.35
Initial one-time setup is modest-to-mid scale (~$2.06M) driven by legal/contingency reserves and specialized instrumentation; recurring annual costs are primarily personnel, compliance monitoring and research (~$1.78M/yr).
One-Time Capital Costs
Total: $2.1M
Annual Recurring Costs
Total: $1.8M/yr
Cost Scenarios
📊
Baseline
(baseline)
$1.8M/yr
Normal uneventful year with standard monitoring, routine testing, and no major incidents or R&D activation.
no breach
no public exposure
no R&D activation
🚨
Minor Incident
$2.6M/yr
Localized containment incident or urgent temporal anomaly requiring emergency relocation/extra legal/PR and investigation.
containment compromise
limited public exposure
urgent relocation
🚨
Temporal R&D Program Initiated
$7.3M/yr
Overwatch/management orders creation of an active temporal isolation/R&D program to mitigate propagation risk; large one-time R&D spending plus elevated operations.
evidence of timeline propagation
Overwatch mandates active mitigation
policy decision to fund R&D
Personnel
10.35 total
| Role | Count | Notes |
|---|---|---|
| Security Officer / MTF Agent | 6 | [#3] Dedicated guards for 24/7 coverage (2 per shift × 3 shifts). |
| Research Scientist | 1.5 | [#4] One primary Level-3 researcher (lead) plus ~0.5 FTE supporting researcher. |
| Medical Officer | 0.6 | [#5] Combined part-time physician and part-time psychologist (0.5–0.7 FTE range; mid used). |
| Archivist | 1 | [#8] Dedicated archivist for fabricated records and audits. |
| IT Support | 0.25 | [#8, #9] 0.25 FTE IT support tied to archives and hardened network monitoring. |
| Contained Individual (payroll) | 1 | [#11] SCP-8056 if placed on payroll (nominal stipend or full compensation as per policy); included as a headcount for benefits/admin accounting. |
Confidence Notes
Analyst notes are detailed with line-item estimates, so core recurring and one-time costs are reasonably well defined. Major uncertainty remains around speculative items (large temporal R&D, magnitude of public-exposure responses) which drive wide tails in one-time exposures, so overall confidence is medium.